Novartis concludes acquisition of Chinook Therapeutics Ruchika Sharma13 Aug 2023 12:00 PM ISTBasel: Novartis has announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based biopharmaceutical company...
Remibrutinib could be new effective and fast-acting oral treatment option for chronic spontaneous urticaria: Phase 3 trials Dr. Kamal Kant Kohli12 Aug 2023 11:15 AM ISTSwitzerland: The phase 3 trials REMIX-1 and REMIX-2 have yielded positive top-line results, as announced by Novartis. Trials assessed remibrutinib 25...
Counterfeit medicines worth Rs 2 crore of Augmentin, Pan-D, Urimax-D and others seized from Kolkata warehouse Ruchika Sharma4 Aug 2023 2:30 PM IST"During the raid, counterfeit medicines, worth about Rs 2 crore of leading manufacturers such as Sun Pharmaceutical, Alkem, Cipla, Glenmark, GSK,...
Patent infringement: Roche sues Novartis unit over generic lung disease drug Ruchika Sharma3 Aug 2023 1:30 PM ISTSwiss drugmaker Roche's Genentech subsidiary has accused a Novartis unit of infringing one of its patents by selling a generic version of its...
Submit Revise Protocol for TIN-816 : CDSCO panel Tells Novartis Dr. Divya Colin18 July 2023 6:00 PM ISTNew Delhi: In response to the proposal to conduct the Phase IIa clinical trial of TIN-816 presented by the drug major Novartis, the Subject Expert...
Novartis acquires DTx Pharma for USD 500 million plus milestone payments Ruchika Sharma18 July 2023 12:30 PM ISTThe agreement underscores the Novartis commitment to Neuroscience, one of the company's five core therapeutic areas, and to pursuing innovative...
Novartis gets CDSCO Panel Nod To Import, Market Inclisiran solution for injection Dr. Divya Colin15 July 2023 6:00 PM ISTNew Delhi: After deliberating the interim data of a Phase-III global clinical trial of Inclisiran solution for injection presented by pharmaceutical...
Novartis to appeal to US Court of Appeals to uphold validity of Entresto combination patent Ruchika Sharma8 July 2023 3:00 PM ISTBasel: Novartis has announced that the U.S. District Court for the District of Delaware issued a negative decision regarding the validity of a patent...
Novartis to divest 'front of eye' ophthalmology assets to Bausch + Lomb for up to 2.5 billion Ruchika Sharma3 July 2023 3:30 PM ISTNovartis will continue to supply Xiidra to patients on behalf of Bausch + Lomb, via transitional agreements for a limited period post-close, to ensure...
Aurobindo Pharma arm signs voluntary license with Medicines Patent Pool to develop generic version of Nilotinib Capsules for chronic myeloid leukemia treatment in 44 countries Ruchika Sharma23 Jun 2023 11:51 AM ISTHyderabad: Pharma major, Aurobindo Pharma Limited, has announced that its wholly-owned subsidiary company, Eugia Pharma Specialities Limited, has...
Novartis Gets CDSCO panel okay To Study Monoclonal Antibody Ianalumab Dr. Divya Colin17 Jun 2023 6:00 PM ISTNew Delhi: The drug major Novartis has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Novartis to acquire Chinook Therapeutics for up to USD 3.5 billion in boost to late stage pipeline Ruchika Sharma12 Jun 2023 1:00 PM ISTBasel: Novartis said on Monday it agreed to acquire Seattle-based biotech firm Chinook Therapeutics for up to USD 3.5 billion to boost its...
